Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Laryngoscope|September 12, 2023
Treatment Outcome in Head and Neck Cancer With Distant Metastasis at Initial DiagnosisJo Omata, Yushi Ueki, Yuto Takahashi, et al.
Frontiers in Surgery|February 28, 2022
Predicting Cervical Lymph Node Metastasis Following Endoscopic Surgery in Superficial Head and Neck CarcinomaRyuichi Okabe, Yushi Ueki, Riuko Ohashi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 31, 2025
Concurrent chemoradiotherapy with docetaxel, cisplatin, and fluorouracil for patients with advanced external auditory canal squamous cell carcinoma: comparison with cisplatin-based concurrent chemoradiotherapyYushi Ueki, Yuki Ohno, Shusuke Ohshima, et al.
International Journal of Clinical Oncology|May 5, 2025
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up dataYushi Ueki, Yuki Ohno, Shusuke Ohshima, et al.
Clinical and Translational Radiation Oncology|November 19, 2019
The association between oral candidiasis and severity of chemoradiotherapy-induced dysphagia in head and neck cancer patients: A retrospective cohort studyHirotake Saito, Ryusuke Shodo, Keisuke Yamazaki, et al.
Scientific Reports|August 26, 2024
PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumabTakashi Matsuki, Daisuke Kawakita, Hideaki Takahashi, et al.
Frontiers in Surgery|January 2, 2023
Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 studyKohei Otaki, Takeshi Takahashi, Ryoko Tanaka, et al.
International Journal of Clinical Oncology|October 16, 2023
Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinomaYushi Ueki, Shusuke Ohshima, Yusuke Yokoyama, et al.
Frontiers in Surgery|September 16, 2021
Treatment Outcome of External Auditory Canal Carcinoma: The Utility of Lateral Temporal Bone ResectionKohei Saijo, Yushi Ueki, Ryoko Tanaka, et al.
Annals of Surgical Oncology|January 22, 2016
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 PatientsKuninori Otsuka, Yorihisa Imanishi, Yuichiro Tada, et al.
Pageof 6